Buy Stocks Easy | About Us
June 25, 2022
Buy Stocks Easy | Online Stocks

OPNT


Buy Opiant Pharmaceuticals, Inc. Stock (symbol: OPNT) Easy Online

Company Name: Opiant Pharmaceuticals, Inc.

Symbol: OPNT

Sector: Basic Industries

Industry: Precious Metals

IPO: 2016

OPNT Current Share Price

Today's OPNT ( Opiant Pharmaceuticals, Inc. ) opening price: $14.4897

Yesterday's OPNT ( Opiant Pharmaceuticals, Inc. ) closing price: $14.5600

Opiant Pharmaceuticals, Inc. Stock ( symbol: OPNT ) Price Chart since IPO (2016):

12 Months Opiant Pharmaceuticals, Inc. Stock ( symbol: OPNT ) Price Chart

Popular Questions about Opiant Pharmaceuticals, Inc. Public Stock ( OPNT )

A: Opiant Pharmaceuticals, Inc. stock symbol (also called stock or share ticker) is OPNT

A: Opiant Pharmaceuticals, Inc. IPO (Initial Public Offering) took place on 2016

A: Opiant Pharmaceuticals, Inc.'s stock (OPNT symbol) price at ther IPO (initial Public Offering) was $14.4897

Q: Is OPNT stock worth buying at the moment?

A: The OPNT stock performance since 2019 are rather disappointing. If you had bought 1 share of Opiant Pharmaceuticals, Inc. stock (symbol: OPNT) at the beginning of 2019, at the opening share price of $15.6000, you would be left with exactly $14.4897 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Opiant Pharmaceuticals, Inc. Stock Easy Online

Opiant Pharmaceuticals, Inc. Stock Ticker Price Chart since IPO:





Opiant Pharmaceuticals, Inc. Stock Price Yesterday



 


Opiant Pharmaceuticals, Inc. Stock Price – Last Week




 


Opiant Pharmaceuticals, Inc. Stock Price – Last Month




 


Opiant Pharmaceuticals, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/12/1960158/0/en/Opiant-Pharmaceuticals-Announces-Contract-Extension-of-Second-Tranche-of-Approximately-2-4-Million-from-Biomedical-Advanced-Research-and-Development-Authority-for-Development-of-OP.html
                            

                                
Opiant Pharmaceuticals Announces Contract Extension of Second Tranche of Approximately $2.4 Million from Biomedical Advanced Research and Development Authority for Development of OPNT003, Nasal Nalmefene, for the Treatment of Opioid Overdose

                                
                                
SANTA MONICA, Calif., Dec.  12, 2019  (GLOBE NEWSWIRE) -- Opiant Ph...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4306004-opiant-pharmaceuticals-inc-opnt-ceo-roger-crystal-q3-2019-results-earnings-call-transcript
                            

                                
Opiant Pharmaceuticals, Inc. (OPNT) CEO Roger Crystal on Q3 2019 Results - Earnings Call Transcript

                                
                                
Opiant Pharmaceuticals, Inc. (OPNT) CEO Roger Crystal on Q3 2019 Re...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/05/1941080/0/en/Opiant-Pharmaceuticals-to-Report-Third-Quarter-2019-Financial-Results-and-Host-Conference-Call-and-Webcast-on-Tuesday-November-12.html
                            

                                
Opiant Pharmaceuticals to Report Third Quarter 2019 Financial Results and Host Conference Call and Webcast on Tuesday, November 12

                                
                                
SANTA MONICA, Calif., Nov.  05, 2019  (GLOBE NEWSWIRE) -- Opiant Ph...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/24/1920290/0/en/Opiant-Pharmaceuticals-to-Present-at-the-2019-Cantor-Global-Healthcare-Conference.html
                            

                                
Opiant Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference

                                
                                
SANTA MONICA, Calif., Sept.  24, 2019  (GLOBE NEWSWIRE) -- Opiant P...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4290804-opiant-pharmaceuticals-hidden-gem-upcoming-catalyst
                            

                                
Opiant Pharmaceuticals: A Hidden Gem With Upcoming Catalyst

                                
                                
Based on our model, the value of Narcan Nasal Spray royalty alone s...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/08/27/1907437/0/en/Opiant-Pharmaceuticals-Announces-Presentations-at-Two-Upcoming-Investor-Conferences.html
                            

                                
Opiant Pharmaceuticals Announces Presentations at Two Upcoming Investor Conferences

                                
                                
SANTA MONICA, Calif., Aug.  27, 2019  (GLOBE NEWSWIRE) -- Opiant Ph...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4284223-opiant-pharmaceuticals-inc-opnt-ceo-roger-crystal-q2-2019-results-earnings-call-transcript?source=feed_sector_transcripts
                            

                                
Opiant Pharmaceuticals, Inc. (OPNT) CEO Roger Crystal on Q2 2019 Results - Earnings Call Transcript

                                
                                
Opiant Pharmaceuticals, Inc. (OPNT) CEO Roger Crystal on Q2 2019 Re...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4263346-opiant-pharmaceuticals-inc-opnt-ceo-roger-crystal-q1-2019-results-earnings-call-transcript?source=feed_sector_transcripts
                            

                                
Opiant Pharmaceuticals, Inc. (OPNT) CEO Roger Crystal on Q1 2019 Results - Earnings Call Transcript

                                
                                
Opiant Pharmaceuticals, Inc. (OPNT) CEO Roger Crystal on Q1 2019 Re...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4250412-opiant-pharmaceuticals-inc-opnt-ceo-dr-roger-crystal-q4-2018-results-earnings-call-transcript?source=feed_sector_transcripts
                            

                                
Opiant Pharmaceuticals, Inc. (OPNT) CEO Dr. Roger Crystal on Q4 2018 Results - Earnings Call Transcript

                                
                                
Opiant Pharmaceuticals, Inc. (OPNT) CEO Dr. Roger Crystal on Q4 201...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.